Advertisement
Document › Details
Kiadis Pharma N.V.. (10/19/18). "Press Release: Kiadis Pharma Raises €31.2 Million in a Private Placement of 3.9 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam.
Original document
accessed by [iito] on 2019-03-05
Record changed: 2023-06-05 |
Advertisement
More documents for Kiadis (Group)
- [1] SynOx Therapeutics Ltd.. (7/27/21). "Press Release: SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer". Dublin....
- [2] Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam....
- [3] Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam....
- [4] Kiadis Pharma N.V.. (11/8/18). "Press Release: Kiadis Pharma Strengthens Core Team with Three Senior Appointments". Amsterdam....
- [5] Kiadis Pharma N.V.. (10/18/18). "Press Release: Kiadis Pharma Launches a Private placement of approximately 3.7 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam....
- [6] Kiadis Pharma N.V.. (10/12/18). "Press Release: Kiadis Pharma Provides Regulatory and Clinical Update on ATIR101". Amsterdam....
- [7] Kiadis Pharma N.V.. (8/1/18). "Press Release: Kiadis Pharma Secures €20 Million Debt Financing Facility from Kreos Capital". Amsterdam....
- [8] Kiadis Pharma N.V.. (10/10/17). "Press Release: Kiadis Pharma Raises €18.0 Million in a Private Placement of 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Dui...
- [9] Kiadis Pharma N.V.. (10/9/17). "Press Release: Kiadis Pharma Launches a Private Placement of approximately 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Duive...
- [10] Kiadis Pharma N.V.. (9/5/17). "Press Release: Kiadis Pharma Appoints Karl Hård as Head of Investor Relations and Communications". Amsterdam-Duivendrecht....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top